1 of 4
The global 3D medical imaging services market was valued at $149,492 million in 2016, and is expected to reach $236,809 million by 2023 at a CAGR of 6.7% during the forecast period. 3D imaging is a revolutionary optical imaging technology, which provides enhanced images on 2D platforms. These images are enhanced by the use of 3D image sensors and displays. The emergence of this imaging technique has allowed medical professionals to generate an in-depth image of suspect for better diagnosis. In addition, the technology is being applied in several noninvasive medical procedures such as ultrasound and tomography. Improved imaging and better viewing experience provided by this technology are the major attributes, which fuel its demand.
The major factors that drive the growth of the global 3D medical imaging services market are increase in need for point-of-care imaging and surge in demand for enhanced optical images for better diagnosis of diseases and disorders. However, insufficiency of medical infrastructure, especially in the developing economies and dearth of skilled professionals hamper the market growth. On the contrary, the introduction of improved data storage and information sharing systems such as medical cloud is anticipated to provide create lucrative opportunities for the market expansion.
The global 3D medical imaging services market is segmented based on technique, application, end user, and region. On the basis of technique, the market is categorized into ultrasound, X-ray, magnetic resonance imaging (MRI), and others. X-ray segment is further segmented into radiography, computed tomography, and fluoroscopy. The applications covered in the study include oncology, cardiology, orthopedic, and others. Depending on end user, the market is fragmented into diagnostic centers, hospitals, and research centers. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
KEY BENEFITS FOR STAKEHOLDERS
The study provides an in-depth analysis of the global 3D medical imaging services market along with the current trends and future estimations to elucidate the imminent investment pockets.
Comprehensive analysis of the factors that drive and restrict the market growth is provided in the report.
Comprehensive quantitative analysis of the industry from 2016 to 2023 is provided to enable the stakeholders to capitalize on the prevailing market opportunities.
Extensive analysis of the key segments of the industry helps in understanding the forms and types of 3D medical imaging service used across the globe.
Key market players and their strategies have been analyzed to understand the competitive outlook of the market.
KEY MARKET SEGMENTS
By Technique
Ultrasound
X-ray
Radiography
Computed Tomography
Fluoroscopy
MRI
Others
By Application
Oncology
Cardiology
Orthopedic
Others
By End User
Diagnostic Centers
Hospitals
Research Centers
By Region
North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
Rest of Asia-Pacific
LAMEA
Brazil
Turkey
South Africa
Saudi Arabia
Rest of LAMEA
KEY PLAYERS PROFILED
GE Company (GE Healthcare)
Hitachi Ltd.
Hologic
Planmeca
Materialise NV
Philips Healthcare
Siemens AG (Siemens Healthineers)
Carestream Health
The Esaote Group
Canon Inc.
The major factors that drive the growth of the global 3D medical imaging services market are increase in need for point-of-care imaging and surge in demand for enhanced optical images for better diagnosis of diseases and disorders. However, insufficiency of medical infrastructure, especially in the developing economies and dearth of skilled professionals hamper the market growth. On the contrary, the introduction of improved data storage and information sharing systems such as medical cloud is anticipated to provide create lucrative opportunities for the market expansion.
The global 3D medical imaging services market is segmented based on technique, application, end user, and region. On the basis of technique, the market is categorized into ultrasound, X-ray, magnetic resonance imaging (MRI), and others. X-ray segment is further segmented into radiography, computed tomography, and fluoroscopy. The applications covered in the study include oncology, cardiology, orthopedic, and others. Depending on end user, the market is fragmented into diagnostic centers, hospitals, and research centers. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
KEY BENEFITS FOR STAKEHOLDERS
The study provides an in-depth analysis of the global 3D medical imaging services market along with the current trends and future estimations to elucidate the imminent investment pockets.
Comprehensive analysis of the factors that drive and restrict the market growth is provided in the report.
Comprehensive quantitative analysis of the industry from 2016 to 2023 is provided to enable the stakeholders to capitalize on the prevailing market opportunities.
Extensive analysis of the key segments of the industry helps in understanding the forms and types of 3D medical imaging service used across the globe.
Key market players and their strategies have been analyzed to understand the competitive outlook of the market.
KEY MARKET SEGMENTS
By Technique
Ultrasound
X-ray
Radiography
Computed Tomography
Fluoroscopy
MRI
Others
By Application
Oncology
Cardiology
Orthopedic
Others
By End User
Diagnostic Centers
Hospitals
Research Centers
By Region
North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
Rest of Asia-Pacific
LAMEA
Brazil
Turkey
South Africa
Saudi Arabia
Rest of LAMEA
KEY PLAYERS PROFILED
GE Company (GE Healthcare)
Hitachi Ltd.
Hologic
Planmeca
Materialise NV
Philips Healthcare
Siemens AG (Siemens Healthineers)
Carestream Health
The Esaote Group
Canon Inc.
Note: Product cover images may vary from those shown
2 of 4
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. Porters five forces analysis
3.4. Top player positioning
3.5. Market dynamics
3.5.1. Drivers
3.5.1.1. Upsurge in demand for point-of-care imaging
3.5.1.2. Rise in technological advancements in 3D medical imaging
3.5.1.3. Rise in geriatric population & chronic diseases globally
3.5.2. Restraints
3.5.2.1. Dearth of skilled professionals
3.5.2.2. Unfavorable reimbursement scenario
3.5.3. Opportunity
3.5.3.1. Developing markets offers lucrative opportunities
CHAPTER 4: 3D MEDICAL IMAGING SERVICES MARKET, BY TECHNIQUE
4.1. Overview
4.1.1. Market size and forecast
4.2. Ultrasound
4.2.1. Key trends and opportunities
4.2.2. Market size and forecast
4.2.3. Market analysis, by country
4.3. X-ray
4.3.1. Key trends and opportunities
4.3.2. Market size and forecast
4.3.3. Market analysis, by country
4.3.4. Radiography
4.3.4.1. Market size and forecast
4.3.5. Computed tomography
4.3.5.1. Market size and forecast
4.3.6. Fluoroscopy
4.3.6.1. Market size and forecast
4.4. MRI
4.4.1. Key trends and opportunities
4.4.2. Market size and forecast
4.4.3. Market analysis, by country
4.5. Others
4.5.1. Key trends and opportunities
4.5.2. Market size and forecast
4.5.3. Market analysis, by country
CHAPTER 5: 3D MEDICAL IMAGING SERVICES MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Oncology
5.2.1. Market size and forecast
5.2.2. Market analysis, by country
5.3. Cardiology
5.3.1. Market size and forecast
5.3.2. Market analysis, by country
5.4. Orthopedic
5.4.1. Market size and forecast
5.4.2. Market analysis, by country
5.5. Others
5.5.1. Market size and forecast
5.5.2. Market analysis, by country
CHAPTER 6: 3D MEDICAL IMAGING SERVICES MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Diagnostic centers
6.2.1. Market size and forecast
6.2.2. Market analysis, by country
6.3. Hospitals
6.3.1. Market size and forecast
6.3.2. Market analysis, by country
6.4. Research centers
6.4.1. Market size and forecast
6.4.2. Market analysis, by country
CHAPTER 7: 3D MEDICAL IMAGING SERVICES MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast
7.2. North America
7.2.1. Key market trends and opportunities
7.2.2. North America market size and forecast, by country
7.2.2.1. U.S. market size and forecast, by technique
7.2.2.2. U.S. market size and forecast, by application
7.2.2.3. U.S. market size and forecast, by end user
7.2.2.4. Canada market size and forecast, by technique
7.2.2.5. Canada market size and forecast, by application
7.2.2.6. Canada market size and forecast, by end user
7.2.2.7. Mexico market size and forecast, by technique
7.2.2.8. Mexico market size and forecast, by application
7.2.2.9. Mexico market size and forecast, by end user
7.2.3. North America market size and forecast, by technique
7.2.4. North America market size and forecast, by application
7.2.5. North America market size and forecast, by end user
7.3. Europe
7.3.1. Key market trends and opportunities
7.3.2. Europe market size and forecast, by country
7.3.2.1. UK market size and forecast, by technique
7.3.2.2. UK market size and forecast, by application
7.3.2.3. UK market size and forecast, by end user
7.3.2.4. Germany market size and forecast, by technique
7.3.2.5. Germany market size and forecast, by application
7.3.2.6. Germany market size and forecast, by end user
7.3.2.7. France market size and forecast, by technique
7.3.2.8. France market size and forecast, by application
7.3.2.9. France market size and forecast, by end user
7.3.2.10. Spain market size and forecast, by technique
7.3.2.11. Spain market size and forecast, by application
7.3.2.12. Spain market size and forecast, by end user
7.3.2.13. Rest of Europe market size and forecast, by technique
7.3.2.14. Rest of Europe market size and forecast, by application
7.3.2.15. Rest of Europe market size and forecast, by end user
7.3.3. Europe market size and forecast, by technique
7.3.4. Europe market size and forecast, by application
7.3.5. Europe market size and forecast, by end user
7.4. Asia-Pacific
7.4.1. Key market trends and opportunities
7.4.2. Asia-Pacific market size and forecast, by country
7.4.2.1. Japan market size and forecast, by technique
7.4.2.2. Japan market size and forecast, by application
7.4.2.3. Japan market size and forecast, by end user
7.4.2.4. China market size and forecast, by technique
7.4.2.5. China market size and forecast, by application
7.4.2.6. China market size and forecast, by end user
7.4.2.7. India market size and forecast, by technique
7.4.2.8. India market size and forecast, by application
7.4.2.9. India market size and forecast, by end user
7.4.2.10. Australia market size and forecast, by technique
7.4.2.11. Australia market size and forecast, by application
7.4.2.12. Australia market size and forecast, by end user
7.4.2.13. Rest of Asia-Pacific market size and forecast, by technique
7.4.2.14. Rest of Asia-Pacific market size and forecast, by application
7.4.2.15. Rest of Asia-Pacific market size and forecast, by end user
7.4.3. Asia-Pacific market size and forecast, by technique
7.4.4. Asia-Pacific market size and forecast, by application
7.4.5. Asia-Pacific market size and forecast, by end user
7.5. LAMEA
7.5.1. Key market trends and opportunities
7.5.2. LAMEA market size and forecast, by country
7.5.2.1. Brazil market size and forecast, by technique
7.5.2.2. Brazil market size and forecast, by application
7.5.2.3. Brazil market size and forecast, by end user
7.5.2.4. Turkey market size and forecast, by technique
7.5.2.5. Turkey market size and forecast, by application
7.5.2.6. Turkey market size and forecast, by end user
7.5.2.7. South Africa market size and forecast, by technique
7.5.2.8. South Africa market size and forecast, by application
7.5.2.9. South Africa market size and forecast, by end user
7.5.2.10. Saudi Arabia market size and forecast, by technique
7.5.2.11. Saudi Arabia market size and forecast, by application
7.5.2.12. Saudi Arabia market size and forecast, by end user
7.5.2.13. Rest of LAMEA market size and forecast, by technique
7.5.2.14. Rest of LAMEA market size and forecast, by application
7.5.2.15. Rest of LAMEA market size and forecast, by end user
7.5.3. LAMEA market size and forecast, by technique
7.5.4. LAMEA market size and forecast, by application
7.5.5. LAMEA market size and forecast, by end user
CHAPTER 8: COMPANY PROFILES
8.1. Canon Inc. (Canon Medical Systems USA, Inc.)
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.1.5. Business performance
8.1.6. Key strategic moves and developments
8.2. Carestream Health, Inc.
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product portfolio
8.2.5. Key strategic moves and developments
8.3. Esaote SpA
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product portfolio
8.4. General Electric Company (GE Healthcare)
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.4.5. Business performance
8.4.6. Key strategic moves and developments
8.5. Hitachi Ltd. (Hitachi Healthcare America Corporation)
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.5.5. Business performance
8.5.6. Key strategic moves and developments
8.6. Hologic, Inc.
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.6.5. Business performance
8.6.6. Key strategic moves and developments
8.7. Koninklijke Philips N.V.
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.7.5. Business performance
8.7.6. Key strategic moves and developments
8.8. Materialise NV
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Product portfolio
8.8.5. Business performance
8.8.6. Key strategic moves and developments
8.9. Planmeca OY
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio
8.9.5. Key strategic moves and developments
8.10. Siemens AG
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Business performance
8.10.6. Key strategic moves and developments
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. Porters five forces analysis
3.4. Top player positioning
3.5. Market dynamics
3.5.1. Drivers
3.5.1.1. Upsurge in demand for point-of-care imaging
3.5.1.2. Rise in technological advancements in 3D medical imaging
3.5.1.3. Rise in geriatric population & chronic diseases globally
3.5.2. Restraints
3.5.2.1. Dearth of skilled professionals
3.5.2.2. Unfavorable reimbursement scenario
3.5.3. Opportunity
3.5.3.1. Developing markets offers lucrative opportunities
CHAPTER 4: 3D MEDICAL IMAGING SERVICES MARKET, BY TECHNIQUE
4.1. Overview
4.1.1. Market size and forecast
4.2. Ultrasound
4.2.1. Key trends and opportunities
4.2.2. Market size and forecast
4.2.3. Market analysis, by country
4.3. X-ray
4.3.1. Key trends and opportunities
4.3.2. Market size and forecast
4.3.3. Market analysis, by country
4.3.4. Radiography
4.3.4.1. Market size and forecast
4.3.5. Computed tomography
4.3.5.1. Market size and forecast
4.3.6. Fluoroscopy
4.3.6.1. Market size and forecast
4.4. MRI
4.4.1. Key trends and opportunities
4.4.2. Market size and forecast
4.4.3. Market analysis, by country
4.5. Others
4.5.1. Key trends and opportunities
4.5.2. Market size and forecast
4.5.3. Market analysis, by country
CHAPTER 5: 3D MEDICAL IMAGING SERVICES MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Oncology
5.2.1. Market size and forecast
5.2.2. Market analysis, by country
5.3. Cardiology
5.3.1. Market size and forecast
5.3.2. Market analysis, by country
5.4. Orthopedic
5.4.1. Market size and forecast
5.4.2. Market analysis, by country
5.5. Others
5.5.1. Market size and forecast
5.5.2. Market analysis, by country
CHAPTER 6: 3D MEDICAL IMAGING SERVICES MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Diagnostic centers
6.2.1. Market size and forecast
6.2.2. Market analysis, by country
6.3. Hospitals
6.3.1. Market size and forecast
6.3.2. Market analysis, by country
6.4. Research centers
6.4.1. Market size and forecast
6.4.2. Market analysis, by country
CHAPTER 7: 3D MEDICAL IMAGING SERVICES MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast
7.2. North America
7.2.1. Key market trends and opportunities
7.2.2. North America market size and forecast, by country
7.2.2.1. U.S. market size and forecast, by technique
7.2.2.2. U.S. market size and forecast, by application
7.2.2.3. U.S. market size and forecast, by end user
7.2.2.4. Canada market size and forecast, by technique
7.2.2.5. Canada market size and forecast, by application
7.2.2.6. Canada market size and forecast, by end user
7.2.2.7. Mexico market size and forecast, by technique
7.2.2.8. Mexico market size and forecast, by application
7.2.2.9. Mexico market size and forecast, by end user
7.2.3. North America market size and forecast, by technique
7.2.4. North America market size and forecast, by application
7.2.5. North America market size and forecast, by end user
7.3. Europe
7.3.1. Key market trends and opportunities
7.3.2. Europe market size and forecast, by country
7.3.2.1. UK market size and forecast, by technique
7.3.2.2. UK market size and forecast, by application
7.3.2.3. UK market size and forecast, by end user
7.3.2.4. Germany market size and forecast, by technique
7.3.2.5. Germany market size and forecast, by application
7.3.2.6. Germany market size and forecast, by end user
7.3.2.7. France market size and forecast, by technique
7.3.2.8. France market size and forecast, by application
7.3.2.9. France market size and forecast, by end user
7.3.2.10. Spain market size and forecast, by technique
7.3.2.11. Spain market size and forecast, by application
7.3.2.12. Spain market size and forecast, by end user
7.3.2.13. Rest of Europe market size and forecast, by technique
7.3.2.14. Rest of Europe market size and forecast, by application
7.3.2.15. Rest of Europe market size and forecast, by end user
7.3.3. Europe market size and forecast, by technique
7.3.4. Europe market size and forecast, by application
7.3.5. Europe market size and forecast, by end user
7.4. Asia-Pacific
7.4.1. Key market trends and opportunities
7.4.2. Asia-Pacific market size and forecast, by country
7.4.2.1. Japan market size and forecast, by technique
7.4.2.2. Japan market size and forecast, by application
7.4.2.3. Japan market size and forecast, by end user
7.4.2.4. China market size and forecast, by technique
7.4.2.5. China market size and forecast, by application
7.4.2.6. China market size and forecast, by end user
7.4.2.7. India market size and forecast, by technique
7.4.2.8. India market size and forecast, by application
7.4.2.9. India market size and forecast, by end user
7.4.2.10. Australia market size and forecast, by technique
7.4.2.11. Australia market size and forecast, by application
7.4.2.12. Australia market size and forecast, by end user
7.4.2.13. Rest of Asia-Pacific market size and forecast, by technique
7.4.2.14. Rest of Asia-Pacific market size and forecast, by application
7.4.2.15. Rest of Asia-Pacific market size and forecast, by end user
7.4.3. Asia-Pacific market size and forecast, by technique
7.4.4. Asia-Pacific market size and forecast, by application
7.4.5. Asia-Pacific market size and forecast, by end user
7.5. LAMEA
7.5.1. Key market trends and opportunities
7.5.2. LAMEA market size and forecast, by country
7.5.2.1. Brazil market size and forecast, by technique
7.5.2.2. Brazil market size and forecast, by application
7.5.2.3. Brazil market size and forecast, by end user
7.5.2.4. Turkey market size and forecast, by technique
7.5.2.5. Turkey market size and forecast, by application
7.5.2.6. Turkey market size and forecast, by end user
7.5.2.7. South Africa market size and forecast, by technique
7.5.2.8. South Africa market size and forecast, by application
7.5.2.9. South Africa market size and forecast, by end user
7.5.2.10. Saudi Arabia market size and forecast, by technique
7.5.2.11. Saudi Arabia market size and forecast, by application
7.5.2.12. Saudi Arabia market size and forecast, by end user
7.5.2.13. Rest of LAMEA market size and forecast, by technique
7.5.2.14. Rest of LAMEA market size and forecast, by application
7.5.2.15. Rest of LAMEA market size and forecast, by end user
7.5.3. LAMEA market size and forecast, by technique
7.5.4. LAMEA market size and forecast, by application
7.5.5. LAMEA market size and forecast, by end user
CHAPTER 8: COMPANY PROFILES
8.1. Canon Inc. (Canon Medical Systems USA, Inc.)
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.1.5. Business performance
8.1.6. Key strategic moves and developments
8.2. Carestream Health, Inc.
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product portfolio
8.2.5. Key strategic moves and developments
8.3. Esaote SpA
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product portfolio
8.4. General Electric Company (GE Healthcare)
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.4.5. Business performance
8.4.6. Key strategic moves and developments
8.5. Hitachi Ltd. (Hitachi Healthcare America Corporation)
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.5.5. Business performance
8.5.6. Key strategic moves and developments
8.6. Hologic, Inc.
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.6.5. Business performance
8.6.6. Key strategic moves and developments
8.7. Koninklijke Philips N.V.
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.7.5. Business performance
8.7.6. Key strategic moves and developments
8.8. Materialise NV
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Product portfolio
8.8.5. Business performance
8.8.6. Key strategic moves and developments
8.9. Planmeca OY
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio
8.9.5. Key strategic moves and developments
8.10. Siemens AG
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Business performance
8.10.6. Key strategic moves and developments
Note: Product cover images may vary from those shown
3 of 4
LOADING...
4 of 4
According to a new report titled, 3D medical imaging services Market by Technique, Application and End User: Global Opportunity Analysis and Industry Forecast, 2017-2023" the global 3D medical imaging services market was valued at $149,492 million in 2016, and is projected to reach $236,809 million by 2023, growing at a CAGR of 6.7% from 2017 to 2023. In 2016, the X-ray segment was the highest contributor in 2016 and accounted for about two-fifths share of the global market.
3D medical imaging is an advanced form of imaging technology, which enhances the quality of images and enables healthcare professionals to diagnose the ailments and disorders precisely. It creates visual representations of the interior of the body by utilizing 3D imaging modalities such as a computed tomography scanner, X-ray, as well as by combining two modalities together for better results.
The market for 3D medical imaging is driven by the launch of novel 3D imaging modalities and techniques. These modalities and novel techniques ease the transition to 3D imaging devices, especially in gynecology and obstetrics field, thus supplementing the market growth. Moreover, rise in incidence of chronic diseases and increase in need for point-of care imaging are expected to fuel the market growth. However, high cost of 3D medical imaging technology and unfavorable reimbursement scenario hamper the growth of the market. On the contrary, increase in healthcare expenditure, especially in the developing economies is anticipated to create lucrative opportunities for key market players.
The 3D medical imaging services market is segmented on the basis of technique, application, end user, and region. Based on technique, the market is divided into ultrasound, X-ray, CT scan, MRI, and hybrid imaging. By application, it is classified into oncology, cardiology, orthopedic, and others. Depending on end user, it is fragmented into diagnostic centers, hospitals, and research centers. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key findings of the 3d Medical Imaging Services Market:
The Cardiology segment is expected to be the fastest growing segment during the forecast period.
Diagnostic centers dominated the global 3D medical imaging services market in 2016 and is expected to grow at a CAGR of 5.8% during the forecast period.
Research centers is expected to be the fastest growing segment in the market during the forecast period.
The U.S. dominated the North American 3D medical imaging services market in 2016 and is projected to grow at a CAGR of 4.4% from 2017 to 2023.
India is expected to be the fastest growing country in the Asia-Pacific 3D medical imaging services market during the forecast period.
North America dominated the 3D medical imaging services market. The market growth in North America is primarily a reflection of product innovations and launches resulting from technological advancements. Europe and Asia-Pacific together accounted for around half of the market in 2016. The companies mostly adopted product launch, acquisition, and expansion as their key strategies to keep pace with the changing demands of consumers and strengthen their market position.
The key players operating in the global 3D medical imaging services market are GE Company (GE Healthcare), Hitachi Ltd., Hologic, Planmeca, Materialise NV, Philips Healthcare, Siemens AG (Siemens Healthineers) and Carestream Health, The Esaote Group, Canon Inc. Other players operating in the value chain are Esaote S.P.A, Fonar Corp., Fujifilm Corp., Hitachi Medical Corp, Mindray Medical International Ltd, and Neusoft Medical Systems Co. Ltd.
3D medical imaging is an advanced form of imaging technology, which enhances the quality of images and enables healthcare professionals to diagnose the ailments and disorders precisely. It creates visual representations of the interior of the body by utilizing 3D imaging modalities such as a computed tomography scanner, X-ray, as well as by combining two modalities together for better results.
The market for 3D medical imaging is driven by the launch of novel 3D imaging modalities and techniques. These modalities and novel techniques ease the transition to 3D imaging devices, especially in gynecology and obstetrics field, thus supplementing the market growth. Moreover, rise in incidence of chronic diseases and increase in need for point-of care imaging are expected to fuel the market growth. However, high cost of 3D medical imaging technology and unfavorable reimbursement scenario hamper the growth of the market. On the contrary, increase in healthcare expenditure, especially in the developing economies is anticipated to create lucrative opportunities for key market players.
The 3D medical imaging services market is segmented on the basis of technique, application, end user, and region. Based on technique, the market is divided into ultrasound, X-ray, CT scan, MRI, and hybrid imaging. By application, it is classified into oncology, cardiology, orthopedic, and others. Depending on end user, it is fragmented into diagnostic centers, hospitals, and research centers. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key findings of the 3d Medical Imaging Services Market:
The Cardiology segment is expected to be the fastest growing segment during the forecast period.
Diagnostic centers dominated the global 3D medical imaging services market in 2016 and is expected to grow at a CAGR of 5.8% during the forecast period.
Research centers is expected to be the fastest growing segment in the market during the forecast period.
The U.S. dominated the North American 3D medical imaging services market in 2016 and is projected to grow at a CAGR of 4.4% from 2017 to 2023.
India is expected to be the fastest growing country in the Asia-Pacific 3D medical imaging services market during the forecast period.
North America dominated the 3D medical imaging services market. The market growth in North America is primarily a reflection of product innovations and launches resulting from technological advancements. Europe and Asia-Pacific together accounted for around half of the market in 2016. The companies mostly adopted product launch, acquisition, and expansion as their key strategies to keep pace with the changing demands of consumers and strengthen their market position.
The key players operating in the global 3D medical imaging services market are GE Company (GE Healthcare), Hitachi Ltd., Hologic, Planmeca, Materialise NV, Philips Healthcare, Siemens AG (Siemens Healthineers) and Carestream Health, The Esaote Group, Canon Inc. Other players operating in the value chain are Esaote S.P.A, Fonar Corp., Fujifilm Corp., Hitachi Medical Corp, Mindray Medical International Ltd, and Neusoft Medical Systems Co. Ltd.
Note: Product cover images may vary from those shown
5 of 4
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
